{
    "qwen-v2.5-14b-instruct": [
        {
            "call": "limited-list-referents",
            "context": {
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "qwen-v2.5-14b-instruct",
            "response": [
                "Trastuzumab (Herceptin)",
                "Paclitaxel (Taxol)",
                "Docetaxel (Taxotere)",
                "Lapatinib (Tykerb)",
                "Anastrozole (Arimidex)",
                "Letrozole (Femara)",
                "Exemestane (Aromasin)",
                "Palbociclib (Ibrance)",
                "Everolimus (Afinitor)",
                "Ibrance (Palbociclib)",
                "Olaparib (Lynparza)",
                "Ribociclib (Kisqali)",
                "Abemaciclib (Verzenio)",
                "Neratinib (Nerlynx)",
                "Fulvestrant (Faslodex)",
                "Ixabepilone (Ixempra)",
                "Gemcitabine (Gemzar)",
                "Capecitabine (Xeloda)",
                "Vinorelbine (Navelbine)",
                "Bevacizumab (Avastin)",
                "Toremifene (Fareston)",
                "Denosumab (Prolia)",
                "Trastuzumab emtansine (Kadcyla)",
                "Palbociclib (Ibrance)"
            ]
        }
    ],
    "phi-v4": [
        {
            "call": "limited-list-referents",
            "context": {
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "phi-v4",
            "response": [
                "Trastuzumab (Herceptin)",
                "Palbociclib (Ibrance)",
                "Everolimus (Afinitor)",
                "Lapatinib (Tykerb)",
                "Tamoxifen",
                "Anastrozole (Arimidex)",
                "Exemestane (Aromasin)",
                "Letrozole (Femara)",
                "Bicalutamide (Casodex)",
                "Ribociclib (Kisqali)",
                "Abemaciclib (Verzenio)",
                "Pertuzumab (Perjeta)",
                "Olaparib (Lynparza)",
                "Nab-paclitaxel (Abraxane)",
                "Vinorelbine (Navelbine)",
                "Eribulin (Halaven)",
                "Paclitaxel (Taxol)",
                "Docetaxel (Taxotere)",
                "Doxorubicin (Adriamycin)",
                "Cyclophosphamide",
                "Cisplatin",
                "Epirubicin (Ellence)",
                "Capecitabine (Xeloda)",
                "Bevacizumab (Avastin)"
            ]
        }
    ],
    "mistral-small-instruct-24B": [
        {
            "call": "limited-list-referents",
            "context": {
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "mistral-small-instruct-24B",
            "response": [
                "Tamoxifen (TAM)",
                "Aromasin (Exemestane)",
                "Femara (Letrozole)",
                "Arimidex (Anastrozole)",
                "Herceptin (Trastuzumab)",
                "Kadcyla (Trastuzumab emtansine)",
                "Perjeta (Pertuzumab)",
                "Kisqali (Ribociclib)",
                "Ibrance (Palbociclib)",
                "Verzenio (Abemaciclib)",
                "Faslodex (Fulvestrant)",
                "Xeloda (Capecitabine)",
                "Taxotere (Docetaxel)",
                "Navelbine (Vinorelbine)",
                "Elliptium (Elliptinium acetate)",
                "Halaven (Eribulin)",
                "Abraxane (Paclitaxel)",
                "Gemzar (Gemcitabine)",
                "Xgeva (Denosumab)",
                "Aromasin (Exemestane)",
                "Zometa (Zoledronic acid)",
                "Faslodex (Fulvestrant)",
                "Nolvadex (Tamoxifen)",
                "Xeloda (Capecitabine)",
                "Xgeva (Denosumab)"
            ]
        }
    ],
    "gemma-3": [
        {
            "call": "limited-list-referents",
            "context": {
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "gemma-3",
            "response": [
                "Tamoxifen (Tam)",
                "Fulvestrant (Ful)",
                "Letrozole (Let)",
                "Anastrozole (Ana)",
                "Exemestane (Exe)",
                "Cyclophosphamide (Cy)",
                "Doxorubicin (Dox)",
                "5-Fluorouracil (5-FU)",
                "Paclitaxel (Pac)",
                "Docetaxel (Doc)",
                "Trastuzumab (Her)",
                "Pertuzumab (Per)",
                "Ado-Trastuzumab Emtansine (T-DM1)",
                "Lapatinib (Lap)",
                "Neratinib (Ner)",
                "Olaparib (Ola)",
                "Talazoparib (Tal)",
                "Ribociclib (Rib)",
                "Palbociclib (Pal)",
                "Abemaciclib (Abe)",
                "Capecitabine (Cape)",
                "Vinorelbine (Vin)",
                "Gemcitabine (Gem)",
                "Tucatinib (Tuc)"
            ]
        }
    ],
    "gpt-4o": [
        {
            "call": "limited-list-referents",
            "context": {
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "gpt-4o",
            "response": [
                "Trastuzumab (Herceptin)",
                "Pertuzumab (Perjeta)",
                "Tamoxifen (Nolvadex)",
                "Anastrozole (Arimidex)",
                "Letrozole (Femara)",
                "Exemestane (Aromasin)",
                "Palbociclib (Ibrance)",
                "Ribociclib (Kisqali)",
                "Abemaciclib (Verzenio)",
                "Everolimus (Afinitor)",
                "Olaparib (Lynparza)",
                "Talazoparib (Talzenna)",
                "Capecitabine (Xeloda)",
                "Fulvestrant (Faslodex)",
                "Lapatinib (Tykerb)",
                "Neratinib (Nerlynx)",
                "Atezolizumab (Tecentriq)",
                "Pembrolizumab (Keytruda)",
                "Ado-trastuzumab emtansine (Kadcyla)",
                "Sacituzumab govitecan (Trodelvy)",
                "Alpelisib (Piqray)",
                "Tucatinib (Tukysa)",
                "Trastuzumab deruxtecan (Enhertu)",
                "Goserelin (Zoladex)"
            ]
        }
    ],
    "gpt-4o-mini": [
        {
            "call": "limited-list-referents",
            "context": {
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "gpt-4o-mini",
            "response": [
                "Tamoxifen (NDC: 00054-0123)",
                "Letrozole (NDC: 00054-0134)",
                "Anastrozole (NDC: 00054-0135)",
                "Trastuzumab (NDC: 50242-0140)",
                "Pertuzumab (NDC: 50242-0070)",
                "Lapatinib (NDC: 0069-0070)",
                "Ado-trastuzumab emtansine (NDC: 50242-0160)",
                "Palbociclib (NDC: 00074-6061)",
                "Ribociclib (NDC: 00074-6062)",
                "Abemaciclib (NDC: 00074-6063)",
                "Capecitabine (NDC: 00074-0240)",
                "Doxorubicin (NDC: 00074-0220)",
                "Cyclophosphamide (NDC: 00074-0221)",
                "Docetaxel (NDC: 00074-0222)",
                "Epirubicin (NDC: 00074-0223)",
                "Gemcitabine (NDC: 00074-0224)",
                "Vinorelbine (NDC: 00074-0225)",
                "Exemestane (NDC: 00054-0136)",
                "Fulvestrant (NDC: 00054-0140)",
                "Olaparib (NDC: 0071-0630)",
                "Talazoparib (NDC: 0071-0631)",
                "Neratinib (NDC: 00074-6064)",
                "Eribulin (NDC: 00074-0226)",
                "Tucatinib (NDC: 00074-6065)"
            ]
        }
    ],
    "gpt-4-32k": [
        {
            "call": "limited-list-referents",
            "context": {
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "gpt-4-32k",
            "response": [
                "Anastrozole (Arimidex)",
                "Tamoxifen (Nolvadex)",
                "Letrozole (Femara)",
                "Exemestane (Aromasin)",
                "Trastuzumab (Herceptin)",
                "Pertuzumab (Perjeta)",
                "Toremifene (Fareston)",
                "Fulvestrant (Faslodex)",
                "Palbociclib (Ibrance)",
                "Ribociclib (Kisqali)",
                "Abemaciclib (Verzenio)",
                "Capecitabine (Xeloda)",
                "Eribulin (Halaven)",
                "Gemcitabine (Gemzar)",
                "Lapatinib (Tykerb)",
                "Neratinib (Nerlynx)",
                "Everolimus (Afinitor)",
                "Paclitaxel (Taxol)",
                "Docetaxel (Taxotere)",
                "Doxorubicin (Adriamycin)",
                "Cyclophosphamide (Cytoxan)",
                "Methotrexate (Trexall)",
                "Fluorouracil (Adrucil)",
                "Vinorelbine (Navelbine)"
            ]
        }
    ],
    "gpt-35-turbo-16k": [
        {
            "call": "limited-list-referents",
            "context": {
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "gpt-35-turbo-16k",
            "response": [
                "Tamoxifen (Nolvadex)",
                "Letrozole (Femara)",
                "Anastrozole (Arimidex)",
                "Exemestane (Aromasin)",
                "Fulvestrant (Faslodex)",
                "Palbociclib (Ibrance)",
                "Ribociclib (Kisqali)",
                "Abemaciclib (Verzenio)",
                "Trastuzumab (Herceptin)",
                "Lapatinib (Tykerb)",
                "Pertuzumab (Perjeta)",
                "Ado-trastuzumab emtansine (Kadcyla)",
                "Everolimus (Afinitor)",
                "Palbociclib (Ibrance)",
                "Ribociclib (Kisqali)",
                "Abemaciclib (Verzenio)",
                "Capecitabine (Xeloda)",
                "Vinorelbine (Navelbine)",
                "Eribulin (Halaven)",
                "Paclitaxel (Taxol)",
                "Docetaxel (Taxotere)",
                "Carboplatin",
                "Cisplatin",
                "Doxorubicin (Adriamycin)",
                "Epirubicin"
            ]
        }
    ],
    "o1-mini": [
        {
            "call": "limited-list-referents",
            "context": {
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "o1-mini",
            "response": [
                "Tamoxifen",
                "Letrozole",
                "Anastrozole",
                "Exemestane",
                "Trastuzumab (Herceptin)",
                "Pertuzumab",
                "Bevacizumab (Avastin)",
                "Palbociclib (Ibrance)",
                "Ribociclib (Kisqali)",
                "Abemaciclib (Verzenio)",
                "Fulvestrant (Faslodex)",
                "Everolimus (Afinitor)",
                "Olaparib (Lynparza)",
                "Niraparib (Zejula)",
                "Talazoparib (Talzenna)",
                "Atezolizumab (Tecentriq)",
                "Neratinib (Nerlynx)",
                "Tucatinib (Tukysa)",
                "Pegylated liposomal doxorubicin (Doxil)",
                "Cyclophosphamide",
                "Doxorubicin",
                "Docetaxel",
                "Paclitaxel",
                "Carboplatin"
            ]
        }
    ],
    "anthropic.claude-3-5-sonnet-v1:0": [
        {
            "call": "limited-list-referents",
            "context": {
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "anthropic.claude-3-5-sonnet-v1:0",
            "response": [
                "Tamoxifen (TMX)",
                "Anastrozole (ANA)",
                "Letrozole (LTZ)",
                "Exemestane (EXE)",
                "Fulvestrant (FUL)",
                "Palbociclib (PAL)",
                "Ribociclib (RIB)",
                "Abemaciclib (ABE)",
                "Trastuzumab (TRA)",
                "Pertuzumab (PER)",
                "Ado-trastuzumab emtansine (T-DM1)",
                "Neratinib (NER)",
                "Lapatinib (LAP)",
                "Everolimus (EVE)",
                "Alpelisib (ALP)",
                "Olaparib (OLA)",
                "Talazoparib (TAL)",
                "Sacituzumab govitecan (SG)",
                "Atezolizumab (ATE)",
                "Pembrolizumab (PEM)",
                "Capecitabine (CAP)",
                "Eribulin (ERI)",
                "Ixabepilone (IXA)",
                "Paclitaxel (PAC)"
            ]
        }
    ],
    "anthropic.claude-3-opus-v1:0": [
        {
            "call": "limited-list-referents",
            "context": {
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "anthropic.claude-3-opus-v1:0",
            "response": [
                "Tamoxifen",
                "Anastrozole (Arimidex)",
                "Letrozole (Femara)",
                "Exemestane (Aromasin)",
                "Fulvestrant (Faslodex)",
                "Toremifene (Fareston)",
                "Raloxifene (Evista)",
                "Palbociclib (Ibrance)",
                "Ribociclib (Kisqali)",
                "Abemaciclib (Verzenio)",
                "Everolimus (Afinitor)",
                "Trastuzumab (Herceptin)",
                "Pertuzumab (Perjeta)",
                "Ado-trastuzumab emtansine (Kadcyla)",
                "Lapatinib (Tykerb)",
                "Neratinib (Nerlynx)",
                "Alpelisib (Piqray)",
                "Tucatinib (Tukysa)",
                "Olaparib (Lynparza)",
                "Talazoparib (Talzenna)",
                "Capecitabine (Xeloda)",
                "Gemcitabine (Gemzar)",
                "Paclitaxel (Taxol)",
                "Docetaxel (Taxotere)"
            ]
        }
    ],
    "anthropic.claude-3-sonnet-v1:0": [
        {
            "call": "limited-list-referents",
            "context": {
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "anthropic.claude-3-sonnet-v1:0",
            "response": [
                "Tamoxifen (TAM)",
                "Anastrozole (ANA)",
                "Letrozole (LET)",
                "Exemestane (EXE)",
                "Fulvestrant (FUL)",
                "Palbociclib (PAL)",
                "Ribociclib (RIB)",
                "Abemaciclib (ABE)",
                "Trastuzumab (TRA)",
                "Pertuzumab (PER)",
                "Ado-Trastuzumab Emtansine (T-DM1)",
                "Neratinib (NER)",
                "Lapatinib (LAP)",
                "Capecitabine (CAP)",
                "Gemcitabine (GEM)",
                "Paclitaxel (PAC)",
                "Docetaxel (DOC)",
                "Doxorubicin (DOX)",
                "Epirubicin (EPI)",
                "Cyclophosphamide (CYC)",
                "Carboplatin (CAR)",
                "Olaparib (OLA)",
                "Talazoparib (TAL)",
                "Alpelisib (ALP)"
            ]
        }
    ],
    "anthropic.claude-3-haiku-v1:0": [
        {
            "call": "limited-list-referents",
            "context": {
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "anthropic.claude-3-haiku-v1:0",
            "response": [
                "Tamoxifen (TAM)",
                "Anastrozole (ANA)",
                "Letrozole (LET)",
                "Exemestane (EXE)",
                "Fulvestrant (FUL)",
                "Palbociclib (PAL)",
                "Ribociclib (RIB)",
                "Abemaciclib (ABE)",
                "Trastuzumab (TRA)",
                "Pertuzumab (PER)",
                "Ado-trastuzumab emtansine (T-DM1)",
                "Lapatinib (LAP)",
                "Neratinib (NER)",
                "Everolimus (EVE)",
                "Olaparib (OLA)",
                "Talazoparib (TAL)",
                "Sacituzumab govitecan (SAC)",
                "Enfortumab vedotin (ENF)",
                "Margetuximab (MAR)",
                "Tucatinib (TUC)",
                "Fam-trastuzumab deruxtecan (T-DXd)",
                "Sacituzumab govitecan-hziy (SAC-H)",
                "Trastuzumab deruxtecan (T-DXd)",
                "Pyrotinib (PYR)"
            ]
        }
    ],
    "meta.llama3-8b-instruct-v1:0": [
        {
            "call": "limited-list-referents",
            "context": {
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "meta.llama3-8b-instruct-v1:0",
            "response": "[\n\"Anastrozole (Arimidex)\" ,\n\"Aromasin (Exemestane)\" ,\n\"Aromatase Inhibitor (Letrozole)\" ,\n\"Aromatase Inhibitor (Fulvestrant)\" ,\n\"Bevacizumab (Avastin)\" ,\n\"Bicalutamide (Casodex)\" ,\n\"Bosutinib (Bosulif)\" ,\n\"Brentuximab Vedotin (Adcetris)\" ,\n\"Capecitabine (Xeloda)\" ,\n\"Cytoxan (Cyclophosphamide)\" ,\n\"Doxorubicin (Adriamycin)\" ,\n\"Docetaxel (Taxotere)\" ,\n\"Endoxifen\" ,\n\"Eribulin (Halaven)\" ,\n\"Everolimus (Afinitor)\" ,\n\"Exemestane (Aromasin)\" ,\n\"Fulvestrant (Faslodex)\" ,\n\"Gefitinib (Iressa)\" ,\n\"Herceptin (Trastuzumab)\" ,\n\"Ixabepilone (Ixempra)\" ,\n\"Lapatinib (Tykerb)\" ,\n\"Letrozole (Femara)\" ,\n\"Mitoxantrone (Novantrone)\" ,\n\"Paclitaxel (Taxol)\" ,\n\"Paclitaxel (Abraxane)\" ,\n\"Palbociclib (Ibrance)\" ,\n\"Ribociclib (Kisqali)\" ,\n\"Tamoxifen\" ,\n\"Trastuzumab (Herceptin)\" ,\n\"Trastuzumab Emtansine (Kadcyla)\" ,\n\"Vinorelbine (Navelbine)\""
        }
    ],
    "meta.llama3-70b-instruct-v1:0": [
        {
            "call": "limited-list-referents",
            "context": {
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "meta.llama3-70b-instruct-v1:0",
            "response": [
                "Abemaciclib (LY2835219)",
                "Ado-trastuzumab emtansine (T-DM1)",
                "Anastrozole (Arimidex)",
                "Atezolizumab (Tecentriq)",
                "Bevacizumab (Avastin)",
                "Capecitabine (Xeloda)",
                "Cisplatin (Platinol)",
                "Docetaxel (Taxotere)",
                "Entrectinib (Rozlytrek)",
                "Everolimus (Afinitor)",
                "Exemestane (Aromasin)",
                "Fulvestrant (Faslodex)",
                "Goserelin (Zoladex)",
                "Ibrance (Palbociclib)",
                "Lapatinib (Tykerb)",
                "Letrozole (Femara)",
                "Neratinib (Nerlynx)",
                "Nintedanib (Vargatef)",
                "Pertuzumab (Perjeta)",
                "Ribociclib (Kisqali)",
                "Tamoxifen (Nolvadex)",
                "Trastuzumab (Herceptin)",
                "Trastuzumab deruxtecan (Enhertu)",
                "Vinorelbine (Navelbine)"
            ]
        }
    ],
    "amazon.titan-text-express-v1": [
        {
            "call": "limited-list-referents",
            "context": {
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "amazon.titan-text-express-v1",
            "response": [
                {
                    "Referent": "Tamoxifen",
                    "Canonical name": "tamoxifen"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Fulvestrant",
                    "Canonical name": "fulvestrant"
                },
                {
                    "Referent": "Aromatase inhibitors",
                    "Canonical name": "aromatase inhibitors"
                },
                {
                    "Referent": "Letrozole",
                    "Canonical name": "letrozole"
                },
                {
                    "Referent": "Anastrozole",
                    "Canonical name": "anastrozole"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                },
                {
                    "Referent": "Exemestane",
                    "Canonical name": "exemestane"
                }
            ]
        }
    ]
}